Insmed Incorporated
Clinical trials sponsored by Insmed Incorporated, explained in plain language.
-
New inhaled drug aims to help lung patients breathe easier and walk farther
Disease control Recruiting nowThis study tests an inhaled powder called treprostinil palmitil for people with high blood pressure in the lungs caused by scarring lung disease. About 344 adults will receive either the drug or a placebo once daily for 24 weeks. The main goal is to see if the drug helps them wal…
Phase: PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated May 17, 2026 02:41 UTC
-
Study offers ongoing TPIP access for lung hypertension patients
Disease control AVAILABLEThis study gives continued access to the inhaled drug TPIP for people with pulmonary arterial hypertension (PAH) or pulmonary hypertension linked to interstitial lung disease (PH-ILD). Only those who finished earlier open-label studies of TPIP can join. The goal is to keep provid…
Sponsor: Insmed Incorporated • Aim: Disease control
Last updated May 11, 2026 20:49 UTC